International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Special issue of Molecular and Cellular signaling of naturally occuring molecules and proteins covers a wide range of signaling molecules such as biosimilar proteins, natural compounds and microbial proteins. The molecules interact with their target extracellular or intracellular receptors to induce cellular and molecular signaling. They eventually cause phenotype changes in cells. For example, anti-inflammatory or pro-inflammatory responses are regulated by the molecules it they bind to target molecules present on cell surfaces and cytoplasmic spaces. Normally, cellular signalings regulated by low molecular weights compounds and receptor-binding ligands have well been known since 1990. Recently, pathogenic bacterial proteins are also being elucidated to interact with their host cells to induce anti- or pro-inflammatory responses through innate immune cells. Therefore, the present special issue covers all the aspect of the above signaling molecules.